'Lack of trust' in medicines prompts UK review
This article was originally published in SRA
Executive Summary
The pharmaceutical industry in the UK will be invited to have its say in a project that will explore concerns by England's chief medical officer that high-profile media debates over certain drugs have damaged trust in clinical researchers, drug companies and doctors1.